Literature DB >> 33940227

Hepatobiliary adverse drug reactions associated with remdesivir: The WHO international pharmacovigilance study.

Min Seo Kim1, Se Yong Jung2, Seung Won Lee3, Han Li4, Ai Koyanagi5, Andreas Kronbichler6, Elena Dragioti7, Kalthoum Tizaoui8, Paul Wasuwanich4, Sung Hwi Hong9, Ramy Abou Ghayda10, Hae Won Yoo11, Hanna Kim12, Louis Jacob13, Joe-Elie Salem14, Karel Kostev15, Youn Ho Shin16, So Young Kim17, Gabriele Gamerith18, Dong Keon Yon19, Jae Il Shin20, Lee Smith21.   

Abstract

Entities:  

Year:  2021        PMID： 33940227     DOI： 10.1016/j.cgh.2021.04.039

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  2 in total

Review 1.  Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis.

Authors:  Matthew J McConnell; Reiichiro Kondo; Nao Kawaguchi; Yasuko Iwakiri
Journal:  Hepatol Commun       Date:  2021-11-10

2.  COVID-19 Morbidity and Severity in Patients With Nonalcoholic Fatty Liver Disease in South Korea: A Nationwide Cohort Study.

Authors:  Hae Won Yoo; Jae Il Shin; Dong Keon Yon; Seung Won Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-24       Impact factor: 13.576
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.